Home › Asset managers › Morgan Stanley › 2024-2025 › Against the board
At least 6,158 proposals in the 2024-2025 proxy season: Morgan Stanley voted against, or withheld its votes from, at least 6,000 proposals put forward by company boards, and voted for 158 shareholder proposals, by its own Form N-PX filings.
Two kinds of vote are listed: a board-sponsored proposal Morgan Stanley voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,158 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Morgan Stanley voted | Funds |
|---|---|---|---|---|---|---|---|
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds | Capital Structure | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds | Capital Structure | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | April 15, 2025 | Approve Use of Idle Raised Funds and Own Funds for Cash Management | Extraordinary Transactions | Board | AGAINST | 1 | |
| CSPC PHARMACEUTICAL GROUP LTD. | May 30, 2025 | Elect Wang Bo as Director | Director Elections | Board | AGAINST | 1 | |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Elect JOHN-LEON, KOO, a Representative of CHUNG YUAN INVESTMENT CO., LTD. with Shareholder No. 883288, as Non-independent Director | Director Elections | Board | AGAINST | 1 | |
| CTBC Financial Holding Co., Ltd. | June 13, 2025 | Approve Issuance of Restricted Stocks | Compensation | Board | AGAINST | 1 | |
| CTBC Financial Holding Co., Ltd. | June 13, 2025 | Elect CHUNG-HUI JIH, with Shareholder No. H220212XXX, as Independent Director | Director Elections | Board | AGAINST | 1 | |
| CTBC Financial Holding Co., Ltd. | June 13, 2025 | Elect DANIEL I. WU, a Representative of YI CHUAN INVESTMENT CO., LTD. with Shareholder No. 883341, as Non-independent Director | Director Elections | Board | AGAINST | 1 | |
| CTS Eventim AG & Co. KGaA | May 21, 2025 | Elect Cornelius Baur to the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| CTS Eventim AG & Co. KGaA | May 21, 2025 | Elect Philipp Westermeyer to the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| CULLINAN THERAPEUTICS INC. | June 12, 2025 | Proposal to vote, on an advisory basis, to approve our named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 1 | |
| CUTERA INC. | July 15, 2024 | Approval of the amendment of outstanding stock options to reduce the exercise price per share to the closing price on the date of the annual meeting. | Compensation | Board | AGAINST | 1 | |
| CUTERA INC. | July 15, 2024 | Election of Directors: Keith Sullivan | Director Elections | Board | AGAINST | 1 | |
| CVR Energy, Inc. | June 5, 2025 | To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| CYTEK BIOSCIENCES INC. | June 18, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2024, as set forth in our proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 1 | |
| CYTOSORBENTS CORP. | June 12, 2025 | To elect the following nominees to serve as directors: Alan D. Sobel, CPA | Director Elections | Board | AGAINST | 1 | |
| CYTOSORBENTS CORP. | June 12, 2025 | To elect the following nominees to serve as directors: Edward R. Jones, MD, MBA | Director Elections | Board | AGAINST | 1 | |
| CYTOSORBENTS CORP. | June 12, 2025 | To elect the following nominees to serve as directors: Michael G. Bator, MBA | Director Elections | Board | AGAINST | 1 | |
| Caesars Entertainment, Inc. | June 10, 2025 | ELECTION OF DIRECTORS: Bonnie S. Biumi | Director Elections | Board | AGAINST | 1 | |
| Caesars Entertainment, Inc. | June 10, 2025 | ELECTION OF DIRECTORS: David P. Tomick | Director Elections | Board | AGAINST | 1 | |
| Caesars Entertainment, Inc. | June 10, 2025 | ELECTION OF DIRECTORS: Don R. Kornstein | Director Elections | Board | AGAINST | 1 | |
| Caesars Entertainment, Inc. | June 10, 2025 | ELECTION OF DIRECTORS: Frank J. Fahrenkopf | Director Elections | Board | AGAINST | 1 | |
| Caesars Entertainment, Inc. | June 10, 2025 | ELECTION OF DIRECTORS: Jan Jones Blackhurst | Director Elections | Board | AGAINST | 1 | |
| CaixaBank SA | April 10, 2025 | Reelect Fernando Maria Costa Duarte Ulrich as Director | Director Elections | Board | AGAINST | 1 | |
| CaixaBank SA | April 10, 2025 | Reelect Teresa Santero Quintilla as Director | Director Elections | Board | AGAINST | 1 | |
| Cal-Maine Foods, Inc. | October 4, 2024 | Election of Directors: Adolphus B. Baker | Director Elections | Board | WITHHOLD | 1 | |
| Cal-Maine Foods, Inc. | October 4, 2024 | Election of Directors: Camille S. Young | Director Elections | Board | WITHHOLD | 1 | |
| Cal-Maine Foods, Inc. | October 4, 2024 | Election of Directors: James E. Poole | Director Elections | Board | WITHHOLD | 1 | |
| Cal-Maine Foods, Inc. | October 4, 2024 | Election of Directors: Letitia C. Hughes | Director Elections | Board | WITHHOLD | 1 | |
| Cal-Maine Foods, Inc. | October 4, 2024 | Election of Directors: Steve W. Sanders | Director Elections | Board | WITHHOLD | 1 | |
| Cameco Corporation | May 9, 2025 | Elect Director Catherine Gignac | Director Elections | Board | AGAINST | 1 | |
| Cameco Corporation | May 9, 2025 | Elect Director Don Kayne | Director Elections | Board | AGAINST | 1 | |
| Cameco Corporation | May 9, 2025 | Elect Director Kathryn (Kate) Jackson | Director Elections | Board | AGAINST | 1 | |
| Cameco Corporation | May 9, 2025 | Elect Director Leontine van Leeuwen-Atkins | Director Elections | Board | AGAINST | 1 | |
| Canadian Imperial Bank of Commerce | April 3, 2025 | Elect Director Nanci E. Caldwell | Director Elections | Board | WITHHOLD | 1 | |
| Canadian National Railway Company | May 2, 2025 | Elect Director Denise Gray | Director Elections | Board | AGAINST | 1 | |
| Canadian Pacific Kansas City Limited | April 30, 2025 | Elect Director John Baird | Director Elections | Board | AGAINST | 1 | |
| Canadian Tire Corporation, Limited | May 8, 2025 | Elect Director Cynthia Trudell | Director Elections | Board | WITHHOLD | 1 | |
| Canadian Tire Corporation, Limited | May 8, 2025 | Elect Director Norman Jaskolka | Director Elections | Board | WITHHOLD | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Asada, Minoru | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Homma, Toshio | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Ikegami, Masayuki | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Ito, Akiko | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Kawamura, Yusuke | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Mitarai, Fujio | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Ogawa, Kazuto | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Suzuki, Masaki | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Takeishi, Hiroaki | Director Elections | Board | AGAINST | 1 | |
| Canon, Inc. | March 28, 2025 | Elect Director Tanaka, Toshizo | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Hirose, Yumi | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Ishida, Yoshinori | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Koda, Main | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Miyazaki, Satoshi | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Mizukoshi, Yutaka | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Muto, Toshiro | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Sasahara, Yoshinobu | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Tsujimoto, Haruhiro | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Tsujimoto, Kenzo | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Tsujimoto, Ryozo | Director Elections | Board | AGAINST | 1 | |
| Capcom Co., Ltd. | June 20, 2025 | Elect Director Yasuko Metcalf | Director Elections | Board | AGAINST | 1 | |
| Carlsberg A/S | March 17, 2025 | Elect Jens Hjorth as New Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Elect Winnie Ma as New Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Reelect Bob Kunze-Concewitz as Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Reelect Henrik Poulsen as Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Reelect Lilian Fossum Biner as Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Reelect Magdi Batato as Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Reelect Majken Schultz as Director | Director Elections | Board | ABSTAIN | 1 | |
| Carlsberg A/S | March 17, 2025 | Reelect Punita Lal as Director | Director Elections | Board | ABSTAIN | 1 | |
| Carrefour SA | May 28, 2025 | Ratify Appointment of Anne Browaeys as Director | Director Elections | Board | AGAINST | 1 |
← Previous Page 44 of 62 Next →
← Back to Morgan Stanley 2024-2025 overview
Built November 8, 2026 from SEC Form N-PX filings.